Literature DB >> 15814992

CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.

Grace L Tan1, Ellena M Peterson.   

Abstract

An evaluation was performed on 95 blood cultures positive for Candida spp. to determine the correlation of direct susceptibility testing of fluconazole versus both standardized disk diffusion and MIC methods. For direct testing, an aliquot taken from BD BACTEC Plus and/or BD BACTEC Lytic/10 bottles (Becton Dickinson [BD], Sparks, MD) positive by gram stain for yeast was subcultured to CHROMagar Candida (BD), and a 25-microg fluconazole disk (BD) was placed on the plate. The area of growth inhibition surrounding the disk was measured at 24 and 48 h. In addition, a subculture of the isolate was tested by a microdilution MIC using YeastOne (TREK Diagnostics Systems Inc., OH) and disk diffusion (NCCLS M44-A) using a standardized inoculum plated onto CHROMagar Candida as well as Mueller-Hinton agar to which 2% glucose and 0.5 microg/ml methylene blue dye was added (MH-GMB). The categorical interpretation derived from the MIC was used as the reference to which the disk diffusion results were compared. There were a total of 41 Candida albicans, 23 Candida glabrata, 20 Candida parapsilosis, 9 Candida tropicalis, and 1 each of Candida krusei and Candida lusitaniae tested. At 24 h there was full agreement among the methods for all C. albicans, C. tropicalis, C. lusitaniae, and C. krusei isolates. For the C. parapsilosis isolates at 24 h there was one very major discrepancy using the direct CHROMagar and one major error with the standardized MH-GMB. The majority of the errors were seen at 24 h with the C. glabrata isolates. Of the 23 C. glabrata isolates at 24 h by direct CHROMagar, there were 10 minor and 1 very major error; by MH-GMB there were 12 minor and 2 very major errors; and by standardized CHROMagar Candida there were 13 minor and 2 major errors. There were no very major errors with C. glabrata when all plates were read at 48 h. At 24 h by the direct and standardized CHROMagar the majority of C. glabrata isolates were more resistant, whereas by MH-GMB they were more susceptible than the reference MIC interpretation. In summary, subculturing yeast directly from blood cultures onto CHROMagar to which a fluconazole disk has been added may provide a presumptive identification at 24 h and, with the exception of C. glabrata, was able to predict the susceptibility to fluconazole with the majority of Candida isolates examined in this evaluation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814992      PMCID: PMC1081328          DOI: 10.1128/JCM.43.4.1727-1731.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  5 in total

1.  Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole.

Authors:  M A Pfaller; D J Diekema; L Boyken; S A Messer; S Tendolkar; R J Hollis
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

Review 2.  The role of antifungal susceptibility testing in the therapy of candidiasis.

Authors:  Duane R Hospenthal; Clinton K Murray; Michael G Rinaldi
Journal:  Diagn Microbiol Infect Dis       Date:  2004-03       Impact factor: 2.803

3.  Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms.

Authors:  A Espinel-Ingroff; M Pfaller; S A Messer; C C Knapp; S Killian; H A Norris; M A Ghannoum
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

4.  Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.

Authors:  Anastasia Antoniadou; Harrys A Torres; Russell E Lewis; John Thornby; Gerald P Bodey; Jeffrey P Tarrand; Xiang-Yang Han; Kenneth V I Rolston; Amar Safdar; Issam I Raad; Dimitrios P Kontoyiannis
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

5.  Direct isolation of Candida spp. from blood cultures on the chromogenic medium CHROMagar Candida.

Authors:  Lynn L Horvath; Duane R Hospenthal; Clinton K Murray; David P Dooley
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

  5 in total
  8 in total

Review 1.  Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing.

Authors:  M A Pfaller; D J Diekema; D J Sheehan
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

2.  Evaluation of direct antifungal susceptibility testing methods of Candida spp. from positive blood culture bottles.

Authors:  Yasemin Oz; Egemen Gokbolat
Journal:  J Clin Lab Anal       Date:  2017-07-13       Impact factor: 2.352

Review 3.  Antifungal Susceptibility Testing: Current Approaches.

Authors:  Elizabeth L Berkow; Shawn R Lockhart; Luis Ostrosky-Zeichner
Journal:  Clin Microbiol Rev       Date:  2020-04-29       Impact factor: 26.132

4.  Chromogenic medium for direct susceptibility testing of Candida spp. isolated from urine.

Authors:  Antônio Alexandre de Vasconcelos; Everardo Albuquerque Menezes; Francisco Afrânio Cunha
Journal:  Mycopathologia       Date:  2011-03-03       Impact factor: 2.574

5.  Agreement of Direct Antifungal Susceptibility Testing from Positive Blood Culture Bottles with the Conventional Method for Candida Species.

Authors:  Kauser Jabeen; Haresh Kumar; Joveria Farooqi; Raunaq Mehboob; Mary E Brandt; Afia Zafar
Journal:  J Clin Microbiol       Date:  2015-11-25       Impact factor: 5.948

6.  Direct Fluconazole Disk Susceptibility Testing for Candida glabrata-Positive Blood Cultures.

Authors:  Sarah Israel; Amichai Perlman; Jacob Moran-Gilad; Maya Korem
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

7.  Association between Antimicrobial Peptide Histatin 5 Levels and Prevalence of Candida in Saliva of Patients with Down Syndrome.

Authors:  Tomoko Komatsu; Kiyoko Watanabe; Nobushiro Hamada; Eva Helmerhorst; Frank Oppenheim; Masaichi Chang-Il Lee
Journal:  Antibiotics (Basel)       Date:  2021-04-26

Review 8.  Application of Culture-Independent Rapid Diagnostic Tests in the Management of Invasive Candidiasis and Cryptococcosis.

Authors:  Michael A Pfaller
Journal:  J Fungi (Basel)       Date:  2015-08-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.